Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Trials to watch in rectal cancer

Jean-Pierre Gerard • 5 Jun 2022
ASCO 2022
Gastrointestinal Cancer Rectal Cancer
PROSPECT

Jean-Pierre Gerard, MD, Centre Antoine Lacassagne, Nice, France, anticipates results from the PROSPECT trial (NCT01515787) for rectal cancer. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Jean-Pierre Gerard

0:54
Highlights in GI cancer at ASCO 2022
Jean-Pierre Gerard • 5 Jun 2022
1:12
The future role of organ preservation in rectal cancer
Jean-Pierre Gerard • 5 Jun 2022
1:48
Evaluating the effects of the OPERA trial in clinical practice
Jean-Pierre Gerard • 5 Jun 2022
3:47
OPERA: contact X-ray brachytherapy in addition to CRT in organ preservation for rectal cancer
Jean-Pierre Gerard • 5 Jun 2022

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals